Premium Nahrungsergänzungsmittel | artgerecht

Cross-Presentation – Immunology Explained Simply

Cross-presentation is an immunological process in which antigen-presenting cells display extracellular antigens via MHC class I molecules to CD8+ T cells. It is essential for immune defense against viruses and tumor cells.

Regular tips about health Regular tips about health

Things worth knowing about "Cross-presentation"

Cross-presentation is an immunological process in which antigen-presenting cells display extracellular antigens via MHC class I molecules to CD8+ T cells. It is essential for immune defense against viruses and tumor cells.

What is Cross-Presentation?

Cross-presentation is a specialized immunological process in which antigen-presenting cells (APCs) – most notably dendritic cells – take up extracellular antigens and present them not via the classical MHC class II pathway, but via MHC class I molecules to cytotoxic CD8+ T cells.

Under normal circumstances, MHC class I molecules exclusively present intracellular antigens, meaning proteins synthesized within the cell itself. Cross-presentation breaks this paradigm, enabling the immune system to mount a cytotoxic T cell response against threats that originate outside the presenting cell.

Importance for the Immune System

Cross-presentation plays a central role in several key immunological processes:

Antiviral defense: Cells that are not directly infected by a virus can still cross-present viral antigens, thereby activating cytotoxic T cells to eliminate infected cells.
Tumor immunity: Tumor antigens can be taken up by dendritic cells and cross-presented to the immune system, triggering an antitumor T cell response.
Vaccine development: Many modern vaccine strategies – especially against cancer and chronic infections – are designed to exploit cross-presentation in order to induce strong CD8+ T cell responses.
Peripheral tolerance: Cross-presentation can also contribute to immune tolerance by preventing excessive responses against self-antigens.

Mechanism of Action

The molecular mechanisms underlying cross-presentation are complex and remain an active area of research. Two major pathways have been identified:

Cytosolic Pathway (Classical Route)

Internalized antigens escape from the phagosome into the cytosol, where they are degraded by the proteasome into small peptide fragments. These peptides are then transported via the TAP transporter (Transporter Associated with Antigen Processing) into the endoplasmic reticulum, where they are loaded onto MHC class I molecules before being trafficked to the cell surface.

Vacuolar Pathway

In this alternative route, antigens remain within the phagosomal-endosomal compartment. The loading of MHC class I molecules with peptides occurs directly inside these vesicles, bypassing the need for cytosolic transport. This pathway is less well characterized but has been functionally demonstrated in several studies.

Cell Types Involved

Cross-presentation is performed primarily by dendritic cells, particularly the subset known as conventional dendritic cells type 1 (cDC1), referred to in humans as BDCA3+ dendritic cells. Under specific conditions, macrophages and certain B cell populations can also perform cross-presentation.

Clinical Relevance

Cross-presentation has significant clinical implications across several fields:

Cancer immunotherapy: Therapeutic tumor vaccines and dendritic cell-based therapies rely on cross-presentation to stimulate anti-tumor CD8+ T cell responses.
Infectious diseases: Failure of cross-presentation can contribute to the persistence of pathogens that infect cells lacking MHC class I expression.
Autoimmune diseases: Dysregulated cross-presentation of self-antigens may lead to the activation of autoreactive T cells and the development of autoimmune conditions.

References

Joffre, O. P. et al. (2012): Cross-presentation by dendritic cells. Nature Reviews Immunology, 12(8), 557–569. DOI: 10.1038/nri3254
Blum, J. S., Wearsch, P. A., Cresswell, P. (2013): Pathways of antigen processing. Annual Review of Immunology, 31, 443–473. DOI: 10.1146/annurev-immunol-032712-095910
Embgenbroich, M., Burgdorf, S. (2018): Current Concepts of Antigen Cross-Presentation. Frontiers in Immunology, 9, 1643. DOI: 10.3389/fimmu.2018.01643

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.